Assessment and predictive ability of the absolute neutrophil count in peripheral blood for in vivo CAR T cells expansion and CRS.
Man ZhangXiaolu LongYi XiaoJin JinCaixia ChenJiao MengWanying LiuAichun LiuLiting ChenPublished in: Journal for immunotherapy of cancer (2023)
Thus, we suggest ANC as an evaluative and predictive biomarker for CAR expansion and CRS during CAR T cell therapy, which can help to maximize clinical efficacy, reduce treatment-related toxicity and prolong survival.